References
- Rodríguez-Ortiz ME, Rodríguez M. Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease. F1000Res. 2020;9:1.
- Komaba H, Zhao J, Yamamoto S, et al. Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS. J Cachexia Sarcopenia Muscle. 2021;12(4):855–6.
- Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int. 2017;92(1):26–36.
- Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2018;13(6):952–961.
- Zhang LX, Zhang B, Liu XY, et al. Advances in the treatment of secondary and tertiary hyperparathyroidism. Front Endocrinol. 2022;13:1059828.
- Xu W, Li S, Cheng F, et al. Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis. Int Urol Nephrol. 2023.
- Peng C, Zhang Z, Liu J, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease. Head Neck. 2017;39(3):564–571.
- Kim HS, Choi BH, Park JR, et al. Delayed surgery for parathyroid adenoma misdiagnosed as a thyroid nodule and treated with radiofrequency ablation. Endocrinol Metab. 2013;28(3):231–235.
- Chen CC, Chen HL, Chiang PL, et al. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study. Int J Hyperthermia. 2022;39(1):907–917.
- Zhang DL, Chen S, Gao MZ, et al. Ultrasound-guided radiofrequency ablation: a new attempt to the treatment of refractory hyperparathyroidism secondary to chronic kidney disease. Kidney Int Rep. 2022;7(2):282–288.
- Qin X, Wang B, Li B, et al. Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism. Ren Fail. 2021;43(1):445–451.
- Zeng Z, Peng CZ, Liu JB, et al. Efficacy of ultrasound-guided radiofrequency ablation of parathyroid hyperplasia: single session vs. two-session for effect on hypocalcemia. Sci Rep. 2020;10(1):6206.
- Liu J, Huang Q, Yang M, et al. Risk factors predicting severe hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism. J Int Med Res. 2020;48(1):300060519897505.
- Rakita A, Nikolić N, Mildner M, et al. Re-epithelialization and immune cell behaviour in an ex vivo human skin model. Sci Rep. 2020;10(1):1.
- Goldfarb M, Gondek SS, Lim SM, et al. Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. World J Surg. 2012;36(6):1314–1319.
- Wei Y, Peng LL, Zhao ZL, et al. Risk factors of severe hypocalcemia after US-guided percutaneous microwave ablation of the parathyroid gland in patients with secondary hyperparathyroidism. J Bone Miner Res. 2020;35(4):691–697.
- Tsai WC, Peng YS, Chiu YL, et al. Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol. 2015;47(7):1203–1207.
- Floege J, Tsirtsonis K, Iles J, et al. Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial. Kidney Int. 2018;93(6):1475–1482.
- Ren M, Zheng D, Wu J, et al. Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study. Sci Rep. 2022;12(1):10289.
- Tentori F, McCullough K, Kilpatrick RD, et al. High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int. 2013;85(1):166–173.